Kansarka qanjirka 'prostate' waa kansarka labaad ee ugu badan ragga adduunka oo dhan, iyadoo lagu qiyaasay 1.276 milyan oo kiis oo cusub oo la soo sheegay sanadkii 2018, oo matalaya 7.1% dhammaan kiisaska kansarka ragga.
Heerka dhimashada ee kansarka qanjirka 'prostate' ayaa sidoo kale sarreeya, iyadoo lagu qiyaasay 37,005 dhimasho adduunka oo dhan sanadkii 2018.
Si kastaba ha noqotee, heerka dhimashada wuxuu si weyn ugu kala duwan yahay gobollada, iyadoo Galbeedka Afrika ay leedahay halista shanaad ee ugu sareysa dhimashada kansarka qanjirka 'prostate' adduunka, iyo Nigeria oo leh dadka ugu badan iyo dhaqaalaha ugu weyn gobolkan.
Nigeria, kansarka qanjirka 'prostate' waa kansarka ugu badan uguna dhimashada badan ragga, iyadoo lagu qiyaasay 32.8 kiis iyo 16.3 dhimasho 100,000 oo ninkiiba.
Tani waa in ka badan laba jibaar heerka dhimashada ee Waqooyiga Ameerika.
Go'aaminta dambe ee cudurka, kheyraadka xaddidan ee baaritaanka iyo ogaanshaha, iyo hoos u dhaca dukumintiga iyo warbixinta kiisaska waxay gacan ka geystaan heerka dhimashada sare ee Nigeria.
Dalka Mareykanka, kansarka qanjirka 'prostate' waa sababta labaad ee ugu badan ee dhimashada kansarka ragga, iyadoo qiyaastii 40,000 oo nin ay u dhintaan cudurka sanad walba.
Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.
Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.
Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.
Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.
Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.
Diidmada masuuliyada: caafimaadka
Boggan waxaa loogu talagalay ujeedooyin waxbarasho iyo macluumaad oo keliya mana aha bixinta talo caafimaad ama adeegyo xirfadeed.
Macluumaadka la bixiyo waa in aan loo isticmaalin in lagu ogaado ama lagu daweeyo dhibaato caafimaad ama cudur, kuwa raadinaya talo caafimaad oo shaqsiyeed waa inay la tashadaan dhakhtar ruqsad haysta.
Fadlan la soco in shabakada neerfaha ee soo saarta jawaabaha su'aalaha, ay tahay mid aan sax ahayn marka ay timaado waxyaabaha tirooyinka ah. Tusaale ahaan, tirada dadka la ogaaday inay qabaan cudur gaar ah.
Had iyo jeer raadi talada dhakhtarkaaga ama daryeel caafimaad oo kale oo u qalma oo ku saabsan xaalad caafimaad. Waligaa ha iska indho tirin talada caafimaadka xirfadeed ama ha dib u dhigin raadinta sababtoo ah wax aad ka akhrisay boggan internetka. Haddii aad u maleyneyso inaad leedahay xaalad caafimaad oo degdeg ah, wac 911 ama u tag qolka gurmadka degdegga ah ee kuugu dhow isla markiiba. Xiriirka dhakhtarka iyo bukaanka looma abuuro boggan internetka ama isticmaalkiisa. BioMedLib ama shaqaalaheeda, ama qof kasta oo ka qaybqaata boggan internetka, ma sameeyaan wax matalaad ah, si cad ama si macquul ah, oo ku saabsan macluumaadka halkan lagu bixiyo ama isticmaalkiisa.
Ogaysiiska: Xuquuqda daabacaadda
Sharciga Xuquuqda daabacaadda ee Digital Millennium ee 1998, 17 U.S.C. § 512 (the DMCA) wuxuu bixiyaa gurmad milkiilayaasha xuquuqda daabacaadda ee aaminsan in waxyaabaha ka muuqda Internetka ay ku xadgudbayaan xuquuqdooda sharciga xuquuqda daabacaadda ee Mareykanka.
Haddii aad si wanaagsan u aaminsan tahay in wax ka mid ah waxyaabaha ku jira boggeena internetka ama adeegyadeena ay ku xadgudbayaan xuquuqdaada daabacaadda, adiga (ama wakiilkaaga) ayaa noo soo diri kara ogeysiis codsanaya in waxyaabaha ku jira ama waxyaabaha laga saaro, ama la xakameeyo helitaanka.
Ogeysiisyada waa in lagu diraa qoraal ahaan emayl (eeg qaybta "Contact" ee cinwaanka emaylka).
DMCA waxay u baahan tahay in ogeysiiskaaga ku saabsan xadgudubka xuquuqda daabacaadda ee la sheegay uu ku jiro macluumaadka soo socda: (1) sharaxaadda shaqada xuquuqda daabacaadda ee ay ku saabsan tahay xadgudubka la sheegay; (2) sharaxaadda nuxurka xadgudubka la sheegay iyo macluumaadka ku filan ee noo oggolaanaya inaan helno nuxurka; (3) macluumaadkaaga xiriirka adiga, oo ay ku jiraan cinwaankaaga, lambarka taleefanka iyo cinwaanka emaylkaaga; (4) bayaan aad ku leedahay aaminaad wanaagsan oo ah in nuxurka habka lagu cabiray uusan oggolaan milkiilaha xuquuqda daabacaadda, ama wakiilkiisa, ama hawlgalka sharci kasta;
(5) bayaan aad saxiixday oo aad ku cadeyneyso in macluumaadka ku jira ogeysiiska uu sax yahay iyo in aad awood u leedahay in aad dhaqan geliso xuquuqda daabacaadda ee la sheeganayo in la jabiyay;
iyo (6) saxiix jireed ama elektaroonig ah oo ka yimid milkiilaha xuquuqda daabacaadda ama qof loo oggol yahay inuu ku dhaqmo magaca milkiilaha xuquuqda daabacaadda.
Haddii aadan ku darin dhammaan macluumaadka kor ku xusan waxay keeni kartaa dib u dhac ku yimaada ka baaraandegista cabashadaada.
Xiriirka
Fadlan noogu soo dir emayl su'aal kasta / soo jeedin.
How deadly is prostate cancer?
Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.
The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.
However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.
In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.
This is more than double the death rate in North America.
Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.
In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.
The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.
Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.
However, early detection and treatment can significantly improve outcomes and reduce mortality rates.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Qiyaastii
BioMedLib waxay isticmaashaa kumbuyuutaro otomaatig ah (algorithms-ka barashada mashiinka) si ay u soo saaraan laba su'aalood iyo jawaabo.
Waxaan ka bilownay 35 milyan oo daabacaadyo caafimaad oo ku saabsan PubMed/Medline. Sidoo kale, bogagga RefinedWeb.
Eeg "Tixraacyada" sidoo kale "Qeexitaanka mas'uuliyadda".
